Siddha medicine for HIV
Phase 1
Completed
- Registration Number
- CTRI/2008/091/000021
- Lead Sponsor
- daykumar Ranga, JNCASR, Bangalore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Seropositive for HIV-1 by three different ELISAs or one ELISA and Western blot confirmation. CD4 clount 200-250 cells per ml. Drug-naive. Both genders. Age above 18 years.
Exclusion Criteria
Presence of opportunistic infections and complications such as Dementia. Signs of acute systemic Illness (CVS, CNS, RS, GU, Liver etc.). Prior-antiretroviral treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HAART:<br>Rapid reduction in viral load<br>Stabilization of or improved CD4 countTimepoint: 3 to 6 months and there after;HIVS 2004:<br>Stabilization or improvement of CD4 count<br>Reduction in viral load<br>Absence of apparant toxic side effectsTimepoint: one to two years
- Secondary Outcome Measures
Name Time Method ILTimepoint: NIL;Overall well being, weight gain, minor infections or complaints, opportunistic infections, malignancies etc<br><br><br><br>Timepoint: During the course of study and at the termination of the clinical trial